« Back to Record
Janssens, A., Berneman, Z. N., Offner, F., Snauwaert, S., Mineur, P., Vanstraelen, G., Meers, S., Spoormans, I., Bron, D., Vande Broek, I., Van Bogaert, C., De Beleyr, B., Smet, A., Nielsen, L., Wapenaar, R., & André, M. (2022). Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study. Clinical Hematology International, 4(4), 133-143. doi:10.1007/s44228-022-00020-8
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/370790



